Tim Sparey
InvestorIndependent Representative of the Investment Advisory Panel at O2h Ventures
London Area, United Kingdom
About
An experienced biotech and pharmaceutical leader in executive and board roles, a founder with 40+ patents and publications who has secured over $6 billion in deals across oncology, CNS, and other areas.
Experience
- Scarlet Therapeutics LtdNon Executive Chaircurrent2026 β present
- Panmure Liberum Cambridge CapitalSenior Advisercurrent2026 β presentCambridge
- EnsiliTechNon Executive Chaircurrent2025 β present
- CamGene TherapeuticsNon Executive Chaircurrent2025 β presentCambridge, England, United Kingdom
- Hawkhill Therapeutics LtdExecutive Chaircurrent2025 β present
- Tay Therapeutics LtdExecutive Chaircurrent2020 β present
- ConcrNon Executive Chaircurrent2020 β presentLondon, England, United Kingdom
- Simon Bennett Associates LtdAssociatecurrent2019 β present
- Cumulus OncologyCBO and Board Director2020 β 2025London and Edinburgh
- VaxEquity LtdManaging Director2020 β 2023
- 3D Consultants Drug Discovery & DevelopmenAssociate2019 β 2023
- GrangeBio Consultants LtdManaging Director2019 β 2023
- Novintum BioscienceCEO & Co-founder2016 β 2018London, United Kingdom
- Midatech Pharma PLCChief Business Officer2014 β 2016Oxford, United Kingdom
- OpsiRx Pharmaceuticals LtdCEO2014 β 2016Cardiff, United Kingdom
- Q Chip LtdChief Executive Officer2012 β 2014Cardiff, United Kingdom
- ProximagenHead of BD2009 β 2012London, United Kingdom
- Merck SeronoHead of BD2008 β 2009
- MerckLicensing Director2005 β 2008
- MerckResearch Fellow1995 β 2005
Skills & more
Pharmaceutics2Life Sciences2Drug Discovery37Technology Transfer21Biotechnology90Lifesciences15Pharmaceutical Industry52Drug Development20Clinical Development58Oncology25Medicinal Chemistry3Biopharmaceuticals14
+2 more
PharmacologyLead ChangeFrom Tim's professional profile.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Andy Morley
Principal at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures
Frequently asked questions
- Who is Tim Sparey?
- An experienced biotech and pharmaceutical leader in executive and board roles, a founder with 40+ patents and publications who has secured over $6 billion in deals across oncology, CNS, and other areas.
- Where does Tim Sparey work?
- Tim Sparey is Independent Representative of the Investment Advisory Panel at O2h Ventures.
- Where did Tim Sparey go to school?
- Tim Sparey studied at University of Warwick (BSc, PhD, Chemistry).
Same school
Also attended University of Warwick154
MariaInvestor at InvestinorChen Yang SiaGeneral Counsel at Golden Gate VenturesMichael CheungInvestment at Makers FundChen YangAdvisor at Golden Gate VenturesSvetlana BenderVice President, Artificial Intelligence & Behavioral Science at Flare Capital PartnersStephen ChambersGeneral Partner at SOSV
+ 148 more
Shared employers
Also worked at CamGene Therapeutics2
Also worked at Cumulus Oncology1
Also worked at Merck106
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 100 more



































